- Home
- GNFT vs GCTS Comparison
GNFT vs GCTS Comparison
Compare GNFT & GCTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GNFT
- GCTS
- Stock Information
- Founded
- GNFT 1999
- GCTS 1998
- Country
- GNFT France
- GCTS United States
- Employees
- GNFT N/A
- GCTS N/A
- Industry
- GNFT Biotechnology: Biological Products (No Diagnostic Substances)
- GCTS Blank Checks
- Sector
- GNFT Health Care
- GCTS Finance
- Exchange
- GNFT Nasdaq
- GCTS Nasdaq
- Market Cap
- GNFT 249.0M
- GCTS 243.2M
- IPO Year
- GNFT 2019
- GCTS N/A
- Fundamental
- Price
- GNFT $5.61
- GCTS $2.57
- Analyst Decision
- GNFT Strong Buy
- GCTS Strong Buy
- Analyst Count
- GNFT 1
- GCTS 1
- Target Price
- GNFT $13.00
- GCTS $8.00
- AVG Volume (30 Days)
- GNFT 20.1K
- GCTS 156.6K
- Earning Date
- GNFT 09-19-2024
- GCTS 11-03-2024
- Dividend Yield
- GNFT N/A
- GCTS N/A
- EPS Growth
- GNFT N/A
- GCTS N/A
- EPS
- GNFT 0.47
- GCTS N/A
- Revenue
- GNFT $86,225,222.00
- GCTS $13,398,000.00
- Revenue This Year
- GNFT $155.44
- GCTS N/A
- Revenue Next Year
- GNFT N/A
- GCTS $574.68
- P/E Ratio
- GNFT $11.07
- GCTS N/A
- Revenue Growth
- GNFT 175.45
- GCTS N/A
- 52 Week Low
- GNFT $2.89
- GCTS $2.35
- 52 Week High
- GNFT $6.05
- GCTS $56.00
- Technical
- Relative Strength Index (RSI)
- GNFT 62.63
- GCTS 38.63
- Support Level
- GNFT $5.12
- GCTS $2.68
- Resistance Level
- GNFT $6.05
- GCTS $3.45
- Average True Range (ATR)
- GNFT 0.28
- GCTS 0.17
- MACD
- GNFT 0.03
- GCTS 0.00
- Stochastic Oscillator
- GNFT 72.11
- GCTS 0.00
About GNFT GENFIT S.A.
Genfit SA is a biotechnology company focused on metabolic and inflammatory diseases, with a particular focus on the liver and gastroenterology. The company's research and development activity relies on its expertise in modulating gene expression through nuclear receptors. Genfit utilizes acquisitions, strategic alliances, and licensing agreements in order to fund the further development of its products. It has one segment the research and development of innovative medicines and diagnostic solutions, the marketing of which depends on the success of the clinical development phase.
About GCTS GCT Semiconductor Holding Inc. Common Stock
GCT Semiconductor Holding Inc. is a designer and supplier of 5G and 4G LTE semiconductor solutions. It enabled fast and reliable 4G LTE connectivity to numerous commercial devices such as CPEs, mobile hotspots, routers, M2M applications and smartphones, etc. The system-on-chip solutions integrate radio frequency, baseband modem and digital signal processing functions, therefore offering complete 4G and 5G platform solutions with small form factors, low power consumption, high performance, high reliability, and cost-effectiveness.